Mitogen-activated protein kinase
From Proteopedia
(Difference between revisions)
| Line 25: | Line 25: | ||
*MAPK1 | *MAPK1 | ||
**[[4g6n]], [[4g6o]], [[4gsb]] – hMAPK1 - human<br /> | **[[4g6n]], [[4g6o]], [[4gsb]] – hMAPK1 - human<br /> | ||
| - | **[[3i5z]], [[3i60]], [[ | + | **[[3i5z]], [[3i60]], [[3w55]], [[2ojg]], [[2oji]], [[2ojj]], [[1wzy]], [[1tvo]], [[3sa0]], [[4fux]], [[4fuy]], [[4fv0]], [[4fv1]], [[4fv2]], [[4fv3]], [[4fv4]], [[4fv5]], [[4fv6]], [[4fv7]], [[4fv8]], [[4fv9]] – hMAPK1+inhibitor - human<br /> |
**[[2y9q]] – hMAPK1 + MAP kinase-interacting Ser/Thr protein kinase peptide<br /> | **[[2y9q]] – hMAPK1 + MAP kinase-interacting Ser/Thr protein kinase peptide<br /> | ||
**[[3tei]] – hMAPK1 (mutant) + ribosomal protein S6 kinase α-1<br /> | **[[3tei]] – hMAPK1 (mutant) + ribosomal protein S6 kinase α-1<br /> | ||
| Line 31: | Line 31: | ||
**[[4fmq]] – hMAPK1 + MAPK docking peptide<br /> | **[[4fmq]] – hMAPK1 + MAPK docking peptide<br /> | ||
**[[4h3q]] – hMAPK1 + MAP2K 2 peptide<br /> | **[[4h3q]] – hMAPK1 + MAP2K 2 peptide<br /> | ||
| - | **[[2z7l]], [[3c9w]], [[3qyw]], [[3qyz | + | **[[2z7l]], [[3c9w]], [[3qyw]], [[3qyz]] - rMAPK1+inhibitor – rat<br /> |
**[[1erk]] - rMAPK1<br /> | **[[1erk]] - rMAPK1<br /> | ||
**[[1gol]], [[3r63]] - rMAPK1 (mutant)<br /> | **[[1gol]], [[3r63]] - rMAPK1 (mutant)<br /> | ||
| Line 88: | Line 88: | ||
*MAPK10 | *MAPK10 | ||
| - | **[[3kvx]], [[3fv8]], [[2waj]], [[3fi2]], [[3fi3]], [[3da6]], [[2zdt]], [[2zdu]], [[3cgf]], [[3cgo]], [[2r9s]], [[2o0u]], [[2o2u]], [[2exc]], [[2b1p]], [[1pmn]], [[ | + | **[[3kvx]], [[3fv8]], [[2waj]], [[3fi2]], [[3fi3]], [[3da6]], [[2zdt]], [[2zdu]], [[3cgf]], [[3cgo]], [[2r9s]], [[2o0u]], [[2o2u]], [[2exc]], [[2b1p]], [[1pmn]], [[4z9l]], [[1pmu]], [[1pmv]], [[3oy1]], [[2ok1]], [[3ttj]], [[3tti]], [[3rtp]], [[3v6r]], [[3v6s]] – hMAPK10+inhibitor<br /> |
**[[3ptg]], [[4h39]] - hMAPK10 catalytic domain + JIP1 peptide <br /> | **[[3ptg]], [[4h39]] - hMAPK10 catalytic domain + JIP1 peptide <br /> | ||
**[[4h36]] – hMAPK10 catalytic domain + ATF2 peptide<br /> | **[[4h36]] – hMAPK10 catalytic domain + ATF2 peptide<br /> | ||
| Line 103: | Line 103: | ||
*MAPK13 | *MAPK13 | ||
| - | **[[3coi]], [[ | + | **[[3coi]], [[4yno]] – hMAPK13<br /> |
**[[4eyj]], [[4eym]] - hMAPK13 +inhibitor<br /> | **[[4eyj]], [[4eym]] - hMAPK13 +inhibitor<br /> | ||
Revision as of 11:09, 17 November 2016
| |||||||||||
3D Structures of Mitogen-activated protein kinase
Updated on 17-November-2016
References
- ↑ Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997 Apr;9(2):180-6. PMID:9069255
- ↑ Aronov AM, Baker C, Bemis GW, Cao J, Chen G, Ford PJ, Germann UA, Green J, Hale MR, Jacobs M, Janetka JW, Maltais F, Martinez-Botella G, Namchuk MN, Straub J, Tang Q, Xie X. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. J Med Chem. 2007 Mar 22;50(6):1280-7. Epub 2007 Feb 15. PMID:17300186 doi:http://dx.doi.org/10.1021/jm061381f

